Feline interferon-ω treatment on canine parvovirus infection

Veterinary Microbiology

Volumn 69, Issue 1-2, 1999, Pages 51-53

  Minagawa, Tomonori ^a   Ishiwata, Kenji ^a   Kajimoto, Tsunesuke ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Animal Health Products Development   (Japan)

Author keywords

Canine parvovirus; Feline interferon; Omega interferon; rFeIFN

Indexed keywords

RECOMBINANT INTERFERON; RECOMBINANT OMEGA INTERFERON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DIARRHEA; DOG; DRUG EFFICACY; DRUG TOLERABILITY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PARVOVIRUS; SYMPTOM; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; CATS; DIARRHEA; DOG DISEASES; DOGS; INTERFERON TYPE I; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; VOMITING;

CANINE PARVOVIRUS; FELIDAE;

EID: 0032840658     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(99)00087-5     Document Type: Conference Paper

References (4)

1. Shimoda, T., Uchino, T., Yamane, Y., Motoyoshi, S, 1997. Treatment effects of feline interferon on canine parvovirus infection (part 2). In: Proc. 18th Annual Meeting of Japanese Society of Clinical Veterinary Medicine, vol. 3, pp. 42-54 (in Japanese).
2. Tateyama S., Prisoeryanto B.P., Yamaguchi R., Uchida K. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours. Res. Vet. Sci. 59:1995;275-277.
3. Ueda Y., Sakurai T., Yanai A. Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product. J. Vet. Med. Sci. 55:1993;251-258.
4. Yamamoto J.K., Okuda T., Yanai A. Antifeline herpesvirus and calicivirus effects of feline interferon. J. Interf. Res. 10:1990;S114.